MT ASCUTNEY HOSPITAL AND HEALTH CENT
1. Target Overview & Investment Thesis
MT ASCUTNEY HOSPITAL AND HEALTH CENT is a 25-bed suburban community hospital in WINDSOR, VT with $59.8M in net patient revenue and a -8.6% operating margin. The hospital serves a payer mix of 56.0% Medicare, 1.5% Medicaid, and 42.5% commercial.
Thesis: Turnaround. Our ML models identify $4.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -8.6% to -1.2% (+736bps).
| Net Revenue HCRIS | $59.8M |
| Current EBITDA COMPUTED | $-5.1M |
| Operating Margin COMPUTED | -8.6% |
| Occupancy HCRIS | 75.3% |
| Revenue / Bed COMPUTED | $2.4M |
| Net-to-Gross HCRIS | 47.6% |
| Distress Probability ML | 42.8% |
2. Market Context & Competitive Position
VT has 16 Medicare-certified hospitals with a median operating margin of -26.6%. The target's margin of -8.6% places it above the state median. Among 9 size-comparable peers (12-50 beds), the median margin is -29.9%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (12-50), prioritizing same-state peers. 9 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| MT ASCUTNEY HOSPITAL AND HEALT (Target) | VT | 25 | $59.8M | -8.6% |
| NORTHEASTERN VT REGIONAL HOPSI | VT | 25 | $105.5M | -7.7% |
| COPLEY HOSPITAL INC. | VT | 25 | $91.4M | -4.3% |
| BRATTLEBORO MEMORIAL HOSPITAL | VT | 47 | $78.9M | -33.4% |
| PORTER HOSPITAL | VT | 25 | $78.1M | -30.6% |
| NORTH COUNTRY HOSPITAL & HEALT | VT | 25 | $70.8M | -41.7% |
| GIFFORD MEDICAL CENTER | VT | 25 | $54.5M | -29.1% |
| SPRINGFIELD HOSPITAL | VT | 25 | $49.5M | -17.0% |
| GRACE COTTAGE HOSPITAL | VT | 19 | $23.2M | -32.4% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.3M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.2M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $1.2M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $728K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $38K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-5.1M |
| + RCM Uplift | +$4.4M |
| Pro Forma EBITDA | $-727K |
| Current Margin | -8.6% |
| Pro Forma Margin | -1.2% |
| WC Released (1x) | $2.3M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-7.9M | $10.2M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-7.9M | $8.7M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-7.1M | $20.6M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-7.1M | $20.4M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-8.7M | $-9.3M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-8.7M | $-13.0M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Heavy Medicare dependence | Medicare comprises 56.0% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 9 hospitals with 12-50 beds
- Same-state prioritization (n=10)
- Comp margins: P25=-32.6% / P50=-29.9% / P75=-14.7%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.